Using a unique murine model for human Crohn?s disease, Fleming researchers identified key molecules that control T lymphocyte migration to the small intestine. Their discovery brings into focus the use of novel, more efficient therapeutic approaches against Crohn?s disease. Please see related press release

• February 11, 2008

Researchers at the Institute of Immunology discover common cellular targets of Tumor Necrosis Factor, a key molecule involved in the pathogenesis of various arthritic and inflammatory bowel diseases. Please see related press release (English) and press release (Greek-VimaScience).

• October 24, 2007

The Al. Fleming Institute participates in CASIMIR, a coordination action of the 6th Framework Programme, focusing on the integration and sustainability of databases containing experimental data and material resources relevant to the use of the mouse as a model organism for human disease. Please see related Press Release

• February 6, 2007

An article from our Centre?s President and Director, Dr George Kollias, on Innovation Policies published in Kathimerini?s Popular Science ? February 2007 Issue ? (see article in Greek).

• January 4, 2007

BSRC "Alexander Fleming" has recently published at PLoS One new work suggesting the use of soluble TNF inhibitors in the treatment of Idiopathic Pulmonary Fibrosis. Related Press Release (Greek) (English) - F1000 Biology

• September 4, 2005

Researchers at the BSRC ‘Al. Fleming’ participated in a cohort of leading International Research Teams towards examining additional, novel functional roles of millions of RNA molecules. Their findings identified that RNA molecules not only serve as the mediators toward protein translation but also play a determining role in the decision making of protein synthesis. Related Press Release (Greek) – PubMed